WebWhat does PHESGO treat? PHESGO ® (pertuzumab, trastuzumab, and hyaluronidase-zzxf) is a prescription medicine approved for use in combination with chemotherapy for:. use prior to surgery (neoadjuvant treatment) in adults with HER2-positive, locally advanced, inflammatory, or early stage breast cancer (tumor is greater than 2 cm in diameter or … WebDownload sample coding information for XOLAIR below. "Download Selected" lets you download and print all selected coding tables. Correct coding is the responsibility of the provider submitting the claim for the item or service. Please check with the payer to verify codes and special billing requirements. Genentech and Novartis Pharmaceuticals ...
50242-245-01 NDC Code Phesgo Human Prescription Drug
WebOct 13, 2024 · If Phesgo is administered during pregnancy, or if a patient becomes pregnant while receiving Phesgo or within 7 months following the last dose of Phesgo, health care providers and patients should immediately report Phesgo exposure to Genentech at 1-888-835-2555. It is unknown if Phesgo passes into breast milk or how it … WebOct 13, 2024 · DESCRIPTION. PHESGO is a combination of pertuzumab, trastuzumab, and hyaluronidase. Pertuzumab is a recombinant humanized monoclonal antibody that targets the extracellular dimerization domain (Subdomain II) of the human epidermal growth factor receptor 2 protein (HER2). Pertuzumab is produced by recombinant DNA technology in a … things to do around moundsville wv
Z51.12 Medical Billing and Coding Forum - AAPC
WebAug 25, 2024 · The initial dose of Phesgo™ is 1,200 mg pertuzumab, 600 mg trastuzumab, and 30,000 units hyaluronidase administered subcutaneously over approximately 8 … WebPertuzumab, Trastuzumab, and Hyaluronidase-zzxf (Phesgo TM) "Notification" New policy developed. Phesgo is considered medically necessary for the treatment of HER2-positive breast cancer when specified medical criteria and guidelines are met. Added HCPCS codes C9399, J3490, J3590, J9999, S0353, and S0354 to Billing/Coding section. References … WebWhat does PHESGO treat? PHESGO ® (pertuzumab, trastuzumab, and hyaluronidase-zzxf) is a prescription medicine approved for use in combination with chemotherapy for:. use prior to surgery (neoadjuvant treatment) in adults with HER2-positive, locally advanced, inflammatory, or early stage breast cancer (tumor is greater than 2 cm in diameter or … salary differential